REFERENCES BIBLIOGRAPHIQUES
~ 46 ~
[108]YUH et al. (2003). Smooth muscle cells improve endothelial cell retention on
polytetrafluoroethylene grafts in vivo. J Vasc Surg. tom 38. pp 557-563.
[109]PELLERIN YLHAC. (2008). Characterization of the Stable and Metastable Poly (ethylene oxide)Urea Complexes in Electrospun Fibers. Journal of Polymer Science Part B: Polymer Physics. Tom 46.
pp 1903-1913
[110]HILL et al. (2003). Circulating endothelial progenitor cells, vascular function, and cardiovascular
risk. N Engl J Med. pp 593-600.
[111]EMERY P. (2002). Dose-effect relationships of non-steroidal antiinflammatory drugs: a literature
review. ClinTher. Tom 24. pp 1225-1291
[112]TULI R, LI WJ, TUAN RS. (2003). Current state of cartilage tissue engineering. Arthritis Res
Ther. 5. pp 8–235.
[113]NETTLES, D. ELDER, S. GILBERT, J. (2002). Potential use of chitosan as a cell scaffold material
for cartilage tissue engineering. Tissue Eng. tom 8. pp 1009–16.
[114]KIM SE et al. (2003). Porous chitosan scaffold containing microspheres loaded with transforming
growth factor-_1: implications for cartilage tissue engineering. J Controlled Release. pp 365–74.
[115]LEE et al. (2004). Effects of the controlled-released TGF-_1 from chitosan microspheres on
chondrocytes cultured in a collagen/chitosan/glycosaminoglycan scaffold. Biomaterials. Tom 25. pp
4163–73.
[116]IWASAKI et al. (2004). Feasibility of polysaccharide hybrid materials for scaffolds in cartilage
tissue engineering: evaluation of chondrocyte adhesion to polyion complex fibers prepared from alginate
and chitosan. Biomacromolecules. Tom 5. pp 33–828.
[117]LAHIJI et al. (2000). Chitosan supports the expression of extracellular matrix proteins in human
osteoblasts and chondrocytes. J Biomed Mater Res. pp 586–95.
[118]RISBUD et al. (2001). In vitro expression of cartilage-specific markers by chondrocytes on a
biocompatible hydrogel: implications for engineering cartilage tissue. Cell Transplant. Tom 10. pp 755–
63.
[119]LU et al. (1999). Effects of chitosan on rat knee cartilages. Biomaterials. Tom 20. pp 1937–44.
[120]OTTERLEI M et al. (1994). Characterization of binding and TNF- alpha- inducing ability of
chitosans on monocyts: the involvement of CD 14. Vaccine. Tom 12. pp 825-832.
[121]GOGEV, S. VERSALI, M..F.ANDTHIRY, E. (2003). Les chitosanes- nouveaux adjuvants pour
la vaccination par voie muqueuse chez les animaux. Ann. Méd. Vét. pp 343-350.
[122]BENESCH, J. (2001). Null Ellipsometry and protein adsorption to model biomaterials. Link-ping
studies in Science and Technology.
[123]SCHLESINGER et al. (1980). The Role of Extra-HepaticTissues in the Receptor·-Mediated
Plasma- Clearance of Glycoproteins Terminated by Mannose Or N-Acetylgfucosamine, Biochemical
Journal. pp 597-606.
[124]PELUSO et al. (1994). Chitosan-Mediated Stimulation of Macrophage Function, Biomaterials.
Tom 15. pp 1215-1220.
~ 46 ~
[108]YUH et al. (2003). Smooth muscle cells improve endothelial cell retention on
polytetrafluoroethylene grafts in vivo. J Vasc Surg. tom 38. pp 557-563.
[109]PELLERIN YLHAC. (2008). Characterization of the Stable and Metastable Poly (ethylene oxide)Urea Complexes in Electrospun Fibers. Journal of Polymer Science Part B: Polymer Physics. Tom 46.
pp 1903-1913
[110]HILL et al. (2003). Circulating endothelial progenitor cells, vascular function, and cardiovascular
risk. N Engl J Med. pp 593-600.
[111]EMERY P. (2002). Dose-effect relationships of non-steroidal antiinflammatory drugs: a literature
review. ClinTher. Tom 24. pp 1225-1291
[112]TULI R, LI WJ, TUAN RS. (2003). Current state of cartilage tissue engineering. Arthritis Res
Ther. 5. pp 8–235.
[113]NETTLES, D. ELDER, S. GILBERT, J. (2002). Potential use of chitosan as a cell scaffold material
for cartilage tissue engineering. Tissue Eng. tom 8. pp 1009–16.
[114]KIM SE et al. (2003). Porous chitosan scaffold containing microspheres loaded with transforming
growth factor-_1: implications for cartilage tissue engineering. J Controlled Release. pp 365–74.
[115]LEE et al. (2004). Effects of the controlled-released TGF-_1 from chitosan microspheres on
chondrocytes cultured in a collagen/chitosan/glycosaminoglycan scaffold. Biomaterials. Tom 25. pp
4163–73.
[116]IWASAKI et al. (2004). Feasibility of polysaccharide hybrid materials for scaffolds in cartilage
tissue engineering: evaluation of chondrocyte adhesion to polyion complex fibers prepared from alginate
and chitosan. Biomacromolecules. Tom 5. pp 33–828.
[117]LAHIJI et al. (2000). Chitosan supports the expression of extracellular matrix proteins in human
osteoblasts and chondrocytes. J Biomed Mater Res. pp 586–95.
[118]RISBUD et al. (2001). In vitro expression of cartilage-specific markers by chondrocytes on a
biocompatible hydrogel: implications for engineering cartilage tissue. Cell Transplant. Tom 10. pp 755–
63.
[119]LU et al. (1999). Effects of chitosan on rat knee cartilages. Biomaterials. Tom 20. pp 1937–44.
[120]OTTERLEI M et al. (1994). Characterization of binding and TNF- alpha- inducing ability of
chitosans on monocyts: the involvement of CD 14. Vaccine. Tom 12. pp 825-832.
[121]GOGEV, S. VERSALI, M..F.ANDTHIRY, E. (2003). Les chitosanes- nouveaux adjuvants pour
la vaccination par voie muqueuse chez les animaux. Ann. Méd. Vét. pp 343-350.
[122]BENESCH, J. (2001). Null Ellipsometry and protein adsorption to model biomaterials. Link-ping
studies in Science and Technology.
[123]SCHLESINGER et al. (1980). The Role of Extra-HepaticTissues in the Receptor·-Mediated
Plasma- Clearance of Glycoproteins Terminated by Mannose Or N-Acetylgfucosamine, Biochemical
Journal. pp 597-606.
[124]PELUSO et al. (1994). Chitosan-Mediated Stimulation of Macrophage Function, Biomaterials.
Tom 15. pp 1215-1220.